These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20482598)

  • 21. Mutations in the peripheral myelin protein zero and connexin32 genes detected by non-isotopic RNase cleavage assay and their phenotypes in Japanese patients with Charcot-Marie-Tooth disease.
    Yoshihara T; Yamamoto M; Doyu M; Mis KI; Hattori N; Hasegawa Y; Mokuno K; Mitsuma T; Sobue G
    Hum Mutat; 2000 Aug; 16(2):177-8. PubMed ID: 10923043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study.
    Nelis E; Van Broeckhoven C; De Jonghe P; Löfgren A; Vandenberghe A; Latour P; Le Guern E; Brice A; Mostacciuolo ML; Schiavon F; Palau F; Bort S; Upadhyaya M; Rocchi M; Archidiacono N; Mandich P; Bellone E; Silander K; Savontaus ML; Navon R; Goldberg-Stern H; Estivill X; Volpini V; Friedl W; Gal A
    Eur J Hum Genet; 1996; 4(1):25-33. PubMed ID: 8800924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Charcot-Marie-Tooth disease: frequency of genetic subtypes in a Southern Italy population.
    Manganelli F; Tozza S; Pisciotta C; Bellone E; Iodice R; Nolano M; Geroldi A; Capponi S; Mandich P; Santoro L
    J Peripher Nerv Syst; 2014 Dec; 19(4):292-8. PubMed ID: 25429913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The clinical presentation and gene mutation of probands in Chinese patients with Charcot-Marie-Tooth disease].
    Liu X; Fan D; Song S
    Zhonghua Nei Ke Za Zhi; 2015 Jul; 54(7):623-7. PubMed ID: 26359026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Charcot-Marie-Tooth disease and related peripheral neuropathies: novel mutations in the peripheral myelin genes connexin 32 (Cx32), peripheral myelin protein 22 (PMP22), and peripheral myelin protein zero (MPZ).
    Ekici AB; Schweitzer D; Park O; Lorek D; Rautenstrauss B; Krüger G; Friedl W; Uhlhaas S; Bathke K; Heuss D; Kayser C; Grehl H
    Neurogenetics; 2000 Sep; 3(1):49-50. PubMed ID: 11085599
    [No Abstract]   [Full Text] [Related]  

  • 26. Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies.
    Silander K; Meretoja P; Juvonen V; Ignatius J; Pihko H; Saarinen A; Wallden T; Herrgård E; Aula P; Savontaus ML
    Hum Mutat; 1998; 12(1):59-68. PubMed ID: 9633821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of GJB1, MPZ, PMP22, EGR2, and LITAF/SIMPLE in Serbian Charcot-Marie-Tooth patients.
    Keckarevic-Markovic M; Milic-Rasic V; Mladenovic J; Dackovic J; Kecmanovic M; Keckarevic D; Savic-Pavicevic D; Romac S
    J Peripher Nerv Syst; 2009 Jun; 14(2):125-36. PubMed ID: 19691535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic diagnosis and molecular pathology of inherited neuropathy].
    Takashima H
    Rinsho Shinkeigaku; 2012; 52(6):399-404. PubMed ID: 22790800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.
    Houlden H; Reilly MM
    Neuromolecular Med; 2006; 8(1-2):43-62. PubMed ID: 16775366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis.
    Fridman V; Bundy B; Reilly MM; Pareyson D; Bacon C; Burns J; Day J; Feely S; Finkel RS; Grider T; Kirk CA; Herrmann DN; Laurá M; Li J; Lloyd T; Sumner CJ; Muntoni F; Piscosquito G; Ramchandren S; Shy R; Siskind CE; Yum SW; Moroni I; Pagliano E; Zuchner S; Scherer SS; Shy ME;
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):873-8. PubMed ID: 25430934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study.
    Ando M; Hashiguchi A; Okamoto Y; Yoshimura A; Hiramatsu Y; Yuan J; Higuchi Y; Mitsui J; Ishiura H; Umemura A; Maruyama K; Matsushige T; Morishita S; Nakagawa M; Tsuji S; Takashima H
    J Peripher Nerv Syst; 2017 Sep; 22(3):191-199. PubMed ID: 28660751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and genetic spectra of Charcot-Marie-Tooth disease in Chinese Han patients.
    Sun B; Chen Z; Ling L; Yang F; Huang X
    J Peripher Nerv Syst; 2017 Mar; 22(1):13-18. PubMed ID: 27862672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families.
    Mostacciuolo ML; Righetti E; Zortea M; Bosello V; Schiavon F; Vallo L; Merlini L; Siciliano G; Fabrizi GM; Rizzuto N; Milani M; Baratta S; Taroni F
    Hum Mutat; 2001; 18(1):32-41. PubMed ID: 11438991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity.
    Young P; Grote K; Kuhlenbäumer G; Debus O; Kurlemann H; Halfter H; Funke H; Ringelstein EB; Stögbauer F
    J Neurol; 2001 May; 248(5):410-5. PubMed ID: 11437164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation.
    Boerkoel CF; Takashima H; Garcia CA; Olney RK; Johnson J; Berry K; Russo P; Kennedy S; Teebi AS; Scavina M; Williams LL; Mancias P; Butler IJ; Krajewski K; Shy M; Lupski JR
    Ann Neurol; 2002 Feb; 51(2):190-201. PubMed ID: 11835375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy.
    Pehlivan D; Beck CR; Okamoto Y; Harel T; Akdemir ZH; Jhangiani SN; Withers MA; Goksungur MT; Carvalho CM; Czesnik D; Gonzaga-Jauregui C; Wiszniewski W; Muzny DM; Gibbs RA; Rautenstrauss B; Sereda MW; Lupski JR
    Genet Med; 2016 May; 18(5):443-51. PubMed ID: 26378787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of the early growth response 2 gene in Japanese patients with Charcot-Marie-Tooth disease type 1.
    Numakura C; Shirahata E; Yamashita S; Kanai M; Kijima K; Matsuki T; Hayasaka K
    J Neurol Sci; 2003 Jun; 210(1-2):61-4. PubMed ID: 12736090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Epidemiology of Charcot-Marie-Tooth Disease in Northern Ostrobothnia, Finland: A Population-Based Study.
    Marttila M; Kytövuori L; Helisalmi S; Kallio M; Laitinen M; Hiltunen M; Kärppä M; Majamaa K
    Neuroepidemiology; 2017; 49(1-2):34-39. PubMed ID: 28810241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysmyelinating and demyelinating Charcot-Marie-Tooth disease associated with two myelin protein zero gene mutations.
    Drac H; Kabzińska D; Moszyńska I; Strugalska-Cynowska H; Hausmanowa-Petrusewicz I; Kochański A
    J Appl Genet; 2011 May; 52(2):177-83. PubMed ID: 21107784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and in silico analysis of 14 novel GJB1, MPZ and PMP22 gene mutations.
    Miltenberger-Miltenyi G; Schwarzbraun T; Löscher WN; Wanschitz J; Windpassinger C; Duba HC; Seidl R; Albrecht G; Weirich-Schwaiger H; Zoller H; Utermann G; Auer-Grumbach M; Janecke AR
    Eur J Hum Genet; 2009 Sep; 17(9):1154-9. PubMed ID: 19259128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.